rpcardioRational Pharmacotherapy in CardiologyРациональная Фармакотерапия в Кардиологии1819-64462225-3653«SILICEA-POLIGRAF» LLC10.20996/1819-6446-2014-10-3-307-311rpcardio-255Research ArticleINNOVATIVE CARDIOLOGYИННОВАЦИОННАЯ КАРДИОЛОГИЯTHE FIRST EXPERIENCE OF LEFT ATRIAL APPENDAGE OCCLUDING DEVICES IMPLANTATION FOR PREVENTION OF STROKE IN THE STATE RESEARCH CENTRE FOR PREVENTIVE MEDICINEПЕРВЫЙ ОПЫТ ИМПЛАНТАЦИИ ОККЛЮЗИРУЮЩИХ УСТРОЙСТВ В УШКО ЛЕВОГО ПРЕДСЕРДИЯ С ЦЕЛЬЮ ПРОФИЛАКТИКИ ИНСУЛЬТОВ В ГОСУДАРСТВЕННОМ НАУЧНО-ИССЛЕДОВАТЕЛЬСКОМ ЦЕНТРЕ ПРОФИЛАКТИЧЕСКОЙ МЕДИЦИНЫДавтянК. В.DavtyanK. V.

д.м.н, руководитель лаборатории рентгенохирургических методов лечения нарушения ритма сердца

101990, Москва, Петроверигский пер., 10

Petroverigsky per. 10, Moscow, 101990 Russia

ТкачеваО. Н.TkachevaO. N.

д.м.н, профессор, первый зам. директора по научной и лечебной работе, руководитель отдела комплексного снижения риска неинфекционных заболеваний

101990, Москва, Петроверигский пер., 10

Petroverigsky per. 10, Moscow, 101990 Russia

КалембергА. А.KalembergA. A.

аспирант

101990, Москва, Петроверигский пер., 10

Petroverigsky per. 10, Moscow, 101990 Russia

kalemberg87@gmail.comКорецкийС. Н.KoretskyS. N.

к.м.н., специалист по функциональной диагностике

101990, Москва, Петроверигский пер., 10

Petroverigsky per. 10, Moscow, 101990 Russia

Государственный научно-исследовательский центр профилактической медициныРоссияState Research Centre for Preventive MedicineRussian Federation201425092015103307311Copyright © Davtyan K.V., Tkacheva O.N., Kalemberg A.A., Koretsky S.N., 20152015Давтян К.В., Ткачева О.Н., Калемберг А.А., Корецкий С.Н.Davtyan K.V., Tkacheva O.N., Kalemberg A.A., Koretsky S.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.rpcardio.online/jour/article/view/255

Some aspects of prevention of thromboembolic events in patients with atrial fibrillation, in particular, the use of implantable left atrial appendage occluding devices are discussed. Along with the literature review on this issue, the results of authors own experience of left atrial appendage occluding devices implantation is presented.

Обсуждается проблема профилактики тромбоэмболических осложнений у пациентов с фибрилляцией предсердий, в частности, имплантация окклюзирующих устройств в ушко левого предсердия. Помимо обзора данных литературы по этой проблеме, представлены результаты собственного опыта по имплантации окклюзирующих устройств в ушко левого предсердия.

фибрилляция предсердийтромбоэмболические осложненияокклюзирующие устройства в ушко левого предсердияatrial fibrillationthromboembolic complicationsleft atrial appendage occluding systemReferencesWolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: Framingham Study. Stroke 1991;22:983-8.Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: Framingham Study. Stroke 1991;22:983-8.Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillations in Olmsted country, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114(2):119-25.Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillations in Olmsted country, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114(2):119-25.Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. NEJM 2011;365:883-91.Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. NEJM 2011;365:883-91.Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. NEJM 2011;365:981-92.Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. NEJM 2011;365:981-92.Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. NEJM 2009;361:1139-51.Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. NEJM 2009;361:1139-51.Levi MM, Eerenberg E, Löwenberg E, Kamphuise PW. Bleeding in patients using new anticoagulants or antiplatelet agents: risk factors and management. Neth J Med 2010;68(2):68-76.Levi MM, Eerenberg E, Löwenberg E, Kamphuise PW. Bleeding in patients using new anticoagulants or antiplatelet agents: risk factors and management. Neth J Med 2010;68(2):68-76.Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996;61(2):755-9.Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996;61(2):755-9.Aberg H. Atrial fibrillation. I. A study of atrial thrombosis and systemic embolism in a necropsy material. Acta medica Scandinavica 1969;185:373-9.Aberg H. Atrial fibrillation. I. A study of atrial thrombosis and systemic embolism in a necropsy material. Acta medica Scandinavica 1969;185:373-9.Stoddard MF, Dawkins PR, Prince CR, Ammash NM. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: A transesophageal echocardiographic study. J Am Coll Cardiol 1995;25:452-9.Stoddard MF, Dawkins PR, Prince CR, Ammash NM. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: A transesophageal echocardiographic study. J Am Coll Cardiol 1995;25:452-9.Camm JA, Colombo A, Corbucci G, Padeletti L. Left atrial appendage closure: a new technique for clinical practice. Heart Rhythm 2014;11(3):514-21.Camm JA, Colombo A, Corbucci G, Padeletti L. Left atrial appendage closure: a new technique for clinical practice. Heart Rhythm 2014;11(3):514-21.Reddy VY, Holmes D, Doshi SK, et al. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation 2011;123(4):417-24.Reddy VY, Holmes D, Doshi SK, et al. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation 2011;123(4):417-24.Hughes S. PREVAIL Yanked From ACC Program; Watchman Device Meets Safety End Point. Availale at: http://www.medscape.com/viewarticle/780535. Accessed by 20.06.2014.Hughes S. PREVAIL Yanked From ACC Program; Watchman Device Meets Safety End Point. Availale at: http://www.medscape.com/viewarticle/780535. Accessed by 20.06.2014.Park JW. Amplatzer Cardiac Plug Post-Market Registry Interim Results. Frankfurt: CSI; 2011;Park JW. Amplatzer Cardiac Plug Post-Market Registry Interim Results. Frankfurt: CSI; 2011;Walsh K. Left atrial appendage closure with the Amplatzer Cardiac Plug: results of the European Prospective Observational Study. Paper presented at: EuroPCR 2012: Congress of the European Association of Percutaneous Cardiovascular Interventions. May 15-18, 2012; Paris, France.Walsh K. Left atrial appendage closure with the Amplatzer Cardiac Plug: results of the European Prospective Observational Study. Paper presented at: EuroPCR 2012: Congress of the European Association of Percutaneous Cardiovascular Interventions. May 15-18, 2012; Paris, France.Lam YY, Yip GW, Yu CM, et al. Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience. Catheter Cardiovasc Interv 2012;79:794-800.Lam YY, Yip GW, Yu CM, et al. Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience. Catheter Cardiovasc Interv 2012;79:794-800.Santoro G. Amplatzer Cardiac Plug: Italian Registry. Paper presented at: XIV International Symposium on Progress in Clinical Pacing 2010. November 30-December 3, 2010; Rome, Italy.Santoro G. Amplatzer Cardiac Plug: Italian Registry. Paper presented at: XIV International Symposium on Progress in Clinical Pacing 2010. November 30-December 3, 2010; Rome, Italy.Guérios EE, Schmid M, Gloekler S, et al. Left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation. Arq Bras Cardiol 2012;98:528-36.Guérios EE, Schmid M, Gloekler S, et al. Left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation. Arq Bras Cardiol 2012;98:528-36.López-Minguez JR, Eldoayen-Gragera J, Gonzalez-Fernandez R, et al. Immediate and one-year results in 35 consecutive patients after closure of left atrial appendage with the Amplatzer Cardiac Plug. Rev Esp Cardiol 2013;66:90-7.López-Minguez JR, Eldoayen-Gragera J, Gonzalez-Fernandez R, et al. Immediate and one-year results in 35 consecutive patients after closure of left atrial appendage with the Amplatzer Cardiac Plug. Rev Esp Cardiol 2013;66:90-7.Ureña M, Rodes-Cabau J, Freixa X, et al. Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy. J Am Coll Cardiol 2013;62:96-102.Ureña M, Rodes-Cabau J, Freixa X, et al. Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy. J Am Coll Cardiol 2013;62:96-102.Kefer J, Vermeersch P, Budts W, et al. Transcatheter left atrial appendage closure for stroke prevention in atrial fibrillation with Amplatzer cardiac plug: the Belgian Registry. Acta Cardiol 2013; 68(6):551-8.Kefer J, Vermeersch P, Budts W, et al. Transcatheter left atrial appendage closure for stroke prevention in atrial fibrillation with Amplatzer cardiac plug: the Belgian Registry. Acta Cardiol 2013; 68(6):551-8.Reddy VY, Möbius-Winkler S, Miller MA, et al. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). J Am Coll Cardiol 2013;61(25):2551-6.Reddy VY, Möbius-Winkler S, Miller MA, et al. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). J Am Coll Cardiol 2013;61(25):2551-6.Tzikas A, Karagounis L, Bouktsi M, Drevelegas Aet al. Left atrial appendage occlusion with the Amplatzer Amulet for stroke prevention in atrial fibrillation: the first case in Greece. Hellenic J Cardiol 2013;54(5):408-12. Поступила: 22.05.2014Tzikas A, Karagounis L, Bouktsi M, Drevelegas Aet al. Left atrial appendage occlusion with the Amplatzer Amulet for stroke prevention in atrial fibrillation: the first case in Greece. Hellenic J Cardiol 2013;54(5):408-12. Поступила: 22.05.2014

The authors declare that there are no conflicts of interest present.